Latest News
PharmaMar and Jazz submit NDA for relapsed small cell lung cancer treatment Lurbinectedin with the US FDA
18 February 2020 - Biopharmaceutical company PharmaMar (MSE:PHM) and Jazz Pharmaceuticals plc (Nasdaq:JAZZ) jointly announced on Monday that a New Drug Application (NDA) has been accepted under the US Food and Drug Administration (FDA) Priority Revie...
GlaxoSmithKline awarded FDA approval for Voltaren Arthritis Pain OTC product for arthritis pain
18 February 2020 - Healthcare company GlaxoSmithKline (LSE:GSK) (NYSE:GSK) reported on Monday the receipt of US Food and Drug Administration (FDA) approval for the Voltaren Arthritis Pain over-the-counter (OTC) product for the relief of arthritis pai...
Mevion Medical Systems names Curt Kienast as COO
18 February 2020 - Cancer proton therapy company Mevion Medical Systems revealed on Monday the election of Curt Kienast as its chief operating officer.With immediate effect, Kienast is responsible for leading the company's end to end processes, ...
Northwell to inaugurate four cardiac catheterization labs following New York State Health and Health Planning Council approval
18 February 2020 - Health care provider Northwell Health said on Monday that it plans to offer cardiology services at its new cardiac catheterization labs at Mather and Plainview hospitals on Long Island following clearance from the New York State He...
Neuropore Therapies announces USD500,000 grant from The ALS Association
18 February 2020 - Biopharmaceutical company Neuropore Therapies Inc revealed on Monday the receipt of a grant, valued at USD500,000, to support the preclinical evaluation and development of its Toll-Like Receptor 2 (TLR2) antagonist NPT1220-312 for ...